Precio FOB
Obtener el precio más reciente|
- Minimum Order
País:
Turkey
N º de Modelo:
-
Precio FOB:
Lugar de origen:
-
Precio de pedido mínimo:
-
Cantidad de pedido mínimo:
-
Detalle de embalaje:
-
El tiempo de entrega:
-
Capacidad de suministro:
-
Tipo de pago:
-
Grupo de productos :
-
Turkey
Persona de contacto Taisa
Giyim Kent 19/57A, Istanbul, Esenler
Venclyxto in combination with obinutuzumab is indicated for the
treatment of adult patients with previously untreated chronic
lymphocytic leukaemia (CLL).
Venclyxto in combination with
rituximab is indicated for the treatment of adult patients with
CLL who have received at least one prior therapy.
Venclyxto monotherapy is
indicated for the treatment of CLL:
• in the presence of *7p deletion
or TP*3 mutation in adult patients who are
unsuitable for or have failed a B-cell receptor pathway
inhibitor,
• in the absence of *7p deletion
or TP*3 mutation in adult patients who have
failed both chemoimmunotherapy and a B-cell receptor pathway
inhibitor.
| País: | Turkey |
| N º de Modelo: | - |
| Precio FOB: | Obtener el precio más reciente |
| Lugar de origen: | - |
| Precio de pedido mínimo: | - |
| Cantidad de pedido mínimo: | - |
| Detalle de embalaje: | - |
| El tiempo de entrega: | - |
| Capacidad de suministro: | - |
| Tipo de pago: | - |
| Grupo de productos : | - |
